4.5 Review

Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins

Journal

BIOCHIMIE
Volume 114, Issue -, Pages 147-154

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biochi.2015.02.005

Keywords

Fragile X syndrome; Fragile X mental retardation protein; Ribosome; Translation; RNA; Neuron

Funding

  1. NIH Molecular Biophysics Training Grant [GM08326]
  2. NIH [R01 GM065265]

Ask authors/readers for more resources

Translational control is a common mechanism used to regulate gene expression and occur in bacteria to mammals. Typically in translational control, an RNA-binding protein binds to a unique sequence in the mRNA to regulate protein synthesis by the ribosomes. Alternatively, a protein may bind to or modify a translation factor to globally regulate protein synthesis by the cell. Here, we review translational control by the fragile X mental retardation protein (FMRP), the absence of which causes the neurological disease, fragile X syndrome (FXS). (C) 2015 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available